Boston Scientific CorporationBSXNYSE
LOADING
|||
R&D Expense Growth Accelerating
Trending higher, above historical average, modest growth trend.
Left:
||||
Year-over-year research & development expense growth
Latest
14.21%
↑ 99% above average
Average (9y)
7.14%
Historical baseline
Range
High:14.21%
Low:-2.64%
CAGR
+7.8%
Consistent expansion
| Period | Value |
|---|---|
| 2024 | 14.21% |
| 2023 | 6.88% |
| 2022 | 9.88% |
| 2021 | 5.34% |
| 2020 | -2.64% |
| 2019 | 5.48% |
| 2018 | 11.63% |
| 2017 | 8.37% |
| 2016 | 5.02% |
| 2015 | 7.22% |